Portfolio company
1Cell.Ai
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops single-cell multi-omic analysis platforms for oncology researchers and drug developers to monitor therapies, discover biomarkers, and study tumour heterogeneity.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
One Biosciences
One Biosciences develops an AI-powered single-cell transcriptomic platform to provide functional tumour profiling for oncologists and pharmaceutical companies.
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
Scailyte
This company develops artificial intelligence software for single-cell data analysis and biomarker discovery for pharmaceutical, clinical and academic research customers.
QuirieGen
This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.
Mission Bio
This company develops single-cell multi-omics analysis platforms for researchers and clinicians to enable precision medicine and drug development.
Phenomic AI
This company develops a machine learning platform for drug discovery through cell imaging and single-cell RNA sequencing for pharmaceutical and biotechnology partners.
Nygen
This company develops cloud-based data platforms that use artificial intelligence to analyse and interpret single-cell genomic datasets for pharmaceutical and academic research teams.
Deepcell
Deepcell develops an artificial intelligence-powered imaging and sorting platform for single-cell morphology analysis, serving life sciences researchers, diagnostic labs, and pharmaceutical companies.
